NCT05136963View on ClinicalTrials.gov

Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Kidney Function Test
Interventions
DRUG

Iohexol

5 milliliter of iohexol will be administrated.

BIOLOGICAL

pharmacokinetics

10 blood samples of 5 milliliter will be performed. sampling time ater administration of Iohexol: 00h30, 1h00, 1h30, 02h00, 03h00, 04h00, 05h00, 06h00, 09h00 and 12h00

Trial Locations (1)

Unknown

Centre Hospitalier Universitaire, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT05136963 - Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance | Biotech Hunter | Biotech Hunter